Marc Beer Impact in the Pharmaceutical Industry

Marc Beer has positively impacted the pharmaceutical industry for the past 25 years. His attitude towards solving problems facing those who are underprivileged is what makes him stand out. Various factors have contributed towards the success of his careers, such as his education and unique flair. Marc kicked off his career at Genzyme (NASDAQ: GENZ) where he served in the sales and marketing division and worked his way up to the Vice President position of Global Marketing.

 

During his time at Genzyme, he promoted the sale of products that would assist roughly 350 million persons who were suffering from rare conditions. Being at the helm of administration in the firm allowed him to promote the product line to those in need of it. Working at this firm motivated him to put in extra effort towards helping the disadvantaged. He wanted to bring hope to those battling with various medical conditions.

 

Given his work history in the industry, Marc was determined to establish his enterprise. He went on to found ViaCell, a biotech firm in 2000 which was aimed at helping the underprivileged. The company had over 300 employees and was set to go public with an Initial Public Offer (IPO) on NASDAQ as VIAC. It was centered on finding a cure for several diseases by protecting the blood stem cells of the umbilical cord.

 

Later in 2007, Marc Beer decided to put up the company for sale and was purchased by PerkinElmer at $300 million. At this time, both his personal and professional life seemed to flourish. However, it was then that everything started to crumble. After Marc sold ViaCell, his wife passed away at 42 years after suffering from a pulmonary embolism.

 

All Marc wanted to do after the demise of his wife was to dedicate all his time to bring up his three children. It was his 14-year old daughter who encouraged him to proceed with his entrepreneur venture. Thanks to her candid advice, her father began another successful enterprise, Renovia. The company originated as an idea from Dr. Ray Iglesias, who shared it with Marc. Learn more: https://www.crunchbase.com/person/marc-beer

 

Dr. Ray Iglesias had spent his years as a gynecologist performing surgeries for women who suffered from pelvic floor conditions. He had dedicated close to ten years of his career looking for alternative solutions for his patients. When he gave a call to Marc, it was the sort of push he needed to make a change in his career. Under an alliance, with the help of Marc, Dr. Iglesias, and Yolanda Lorié, Renovia was founded.

 

A Brief History

 

At some point, Marc Beer served in the pharmaceutical sector as a marketer at Abbott Laboratories (NYSE: ABT). In 1987, he acquired an undergraduate degree in Business from Miami University. He has been a member of the Mass Life Science Board of the Commonwealth of Massachusetts and the Biotechnology Industry Organization (BIO) Emerging Companies Section Governing Board. Marc Beer has also been the chair for different corporations such as Good Start Genetics, Inc. and Minerva Neurosciences Inc. (NASDAQ: NERV).

Follow Marc Beer on Facebook

Leave a Reply

Your email address will not be published. Required fields are marked *